Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 20,000 shares at $14.79 ($296K) on 2022-10-07, disclosed to the SEC on 2022-10-11.
Open-market sale of $296k CTKB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |